Rise in Prevalence of Hypertension Expected to Drive Global Antihypertensive Drugs Market: Ken Research REQUEST FOR SAMPLE REPORT Buy Now Request For sample Report × Report Title Name Email Designation Phone No Comapny Name Comapny URL Country -- Please Select Your Country -- Afganistan Africa Albania Algeria Andorra Angola Anguilla Antigua and Barbuda Argentina Armenia Aruba Asia Australasia Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bonaire Bosnia Herzegovina Botswana Brazil BRICS British Virgin Islands Brunei Darussalam Bulgaria Burkina Faso Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Central and South America Chad Chile China Colombia Comoros Congo Costa Rica Cote d'Ivoire Croatia Cuba Curacao Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Europe European Union Falkland Islands Faroe Islands Fiji Finland France French Guiana French Polynesia Gabon Gambia Georgia Germany Ghana Gibraltar Global Great Britain Greece Greenland Grenada Guadeloupe Guam Guatemala Guerney & Alderney Guinea Guinea-Bissau Guyana Haiti Honduras Hong Kong Hungary Iceland India Indonesia Iran Iraq Ireland Isle of Man Israel Italy Ivory Coast Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kosovo Kuwait Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Liechtenstein Lithuania Luxembourg Macao Macau Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Man (Island of) Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Micronesia Middle East Minnesota Moldova Monaco Mongolia Monserrat Montenegro Morocco Morroco Mozambique Myanmar Namibia Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria Niue North America North Korea Norway Oman Pakistan Palau Palestine Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Puerto Rico Qatar Reunion Romania Russia Rwanda Saint Helena Saint Lucia Saint Martin Saint Pierre and Miquelon Saint Vincent and the Grenadines Samoa Samoa (American) San Marino Sao Tome and Principe Saudi Arabia Scandinavia Senegal Serbia Seychelles Sierra Leone Singapore Sint Maarten Slovakia Slovenia Solomon (Islands) Somalia South Africa South Korea South Sudan Spain Sri Lanka Sudan Suriname Svalbard and Jan Mayen Islands Swaziland Sweden Switzerland Syria Taiwan Tajikistan Tanzania Thailand Timor Leste Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Uganda Ukraine United Arab Emirates United Kingdom United States Uruguay Uzbekistan Vanuatu Vatican City Venezuela Vietnam Virgin Islands Western Sahara Yemen Zambia Zimbabwe Requirement Submit Antihypertensive drugs consist of a class of drugs that are primarily used in treating hypertension. Hypertension is a condition wherein the blood pressure in arteries is increased to persistently high value. High blood pressure also increases the risk associated with heart failure, and heart diseases stroke. Hypertension also leads to some of the other problems associated with renal impairment, visual impairment, and retinal haemorrhage. According to study, “Antihypertensive Drugs Market by Therapeutic Class (Diuretics, ACE Inhibitors, Calcium Channel Blockers, Vasodilators, Beta-adrenergic Blockers, and Others) and Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-commerce, and Others Distribution Channel): Global Opportunity Analysis and Industry Forecast, 2019-2026”. Some of the key companies operating in the antihypertensive drugs market are Boehringer Ingelheim GmbH, Sanofi S.A., Johnson and Johnson, Merck KGaA, Bayer AG, Pfizer, Inc., AstraZeneca Plc., Takeda Pharmaceutical Co., Ltd., Daiichi Sankyo Company, and Novartis International AG. The key players are enhancing the product portfolio, and business strategies to gain market share. Based on therapeutic class, antihypertensive drugs market is segmented into diuretics, beta-adrenergic blockers, calcium channel blockers, Angiotensin Converting Enzyme (ACE) inhibitors, vasodilators, and others. Diuretics segment is further sub-segmented into loop diuretics, a thiazide diuretic, and potassium-sparing diuretics. The beta-blockers segment is also sub-segmented into beta-1 selective and intrinsic sympathomimetic. Calcium channel blockers hold a major share in the market owing to reduced side effects exhibited by drugs as compared to other antihypertensive drugs. However, the ACE inhibitors segment is further anticipated to depict significant growth over the forecast period. Some of the key benefits associated include a positive impact on overall health and a decrease in the progression of kidney diseases. Based on the condition, the market is segmented into primary hypertension and secondary hypertension. Based on medication type, the market is segmented into combination therapy, monotherapy, and fixed-dose combinations. In addition, based on the distribution channel, the market is segmented into hospital pharmacy, retail pharmacy, and e-commerce. The hospital segment held the largest share which is attributed to a rise in the number of hospitals globally. Furthermore, antihypertensive drugs are the prescription-based medications that are widely prescribed by healthcare experts available in hospitals further augmenting the growth of. The e-commerce segment is further expected to exhibit the highest growth over the forecast period, owing to a surge in the use of the internet globally. The antihypertensive drugs market is driven by a surge in healthcare expenditure, followed by growth in geriatric population, increase in initiatives by private & government organizations and rise in the prevalence of hypertension across the globe. However, patent expirations of blockbuster drugs may impact the market. Based on geography, the North-American region dominates the global antihypertensive drugs market owing to the easy availability of antihypertensive drugs and rise in incidence of hypertension in the region. Whereas, the Asian-Pacific and European regions are estimated to witness higher growth rate due to constantly evolving life science industry and a surge in awareness related to the use of antihypertensive drugs over the forecast period. The global antihypertensive the market accounted for the US $22,557 million in 2018 and is anticipated to reach the US $28,797 million by 2026, registering a CAGR of 3.1% from 2019-2026. For More Information on the Research Report, refer to below links: – Global Antihypertensive Drugs Market Analysis Related Report: – Global and Asia Antihypertensive Drugs Market Status and Future Forecast 2013-2023 Contact Us: – Ken Research Ankur Gupta, Head Marketing & Communications Ankur@kenresearch.com +91-9015378249 Tags: Asia-Pacific Antihypertensive Drugs Market, AstraZeneca Antihypertensive Drugs Market Outlook, Bayer AG Antihypertensive Drugs Market Growth, Europe Antihypertensive Drugs Market, Global ACE Inhibitors Drugs Market, Global Antihypertensive Drugs Industry, Global Antihypertensive Drugs Industry Research Report, Global Antihypertensive Drugs Market, Global Antihypertensive Drugs Market Analysis, Global Antihypertensive Drugs Market Forecast, Global Antihypertensive Drugs Market Future Outlook, Global Antihypertensive Drugs Market Growth Rate, Global Antihypertensive Drugs Market Major Players, Global Antihypertensive Drugs Market Research Report, Global Antihypertensive Drugs Market Revenue, Global Antihypertensive Drugs Market Share, Global Antihypertensive Drugs Market Size, Global Beta-adrenergic Blockers Drugs Market, Global Calcium Channel Blockers Drugs Market, Global Diuretics Antihypertensive Drugs Market, Global Vasodilators Antihypertensive Drugs Market, Johnson and Johnson Antihypertensive Drugs Market Size, Merck KGaA Antihypertensive Drugs Market Analysis, North America Antihypertensive Drugs Market, Pfizer Antihypertensive Drugs Market Sales Revenue, Saudi Arabia Antihypertensive Drugs Market